University of Wisconsin-Madison (UW) wields clout in the research community. According to their website, they rank sixth nationwide in volume of research; representing $1 billion in annual research investment in 17 research and service centers.
Channel 3000 recently reported on UW’s entry into the “All of Us” study—one of the most ambitious medical research projects of this era. With a goal of recruiting 1 million participants over the next five years, UW forecasts 100,000 will originate from UW. Already, more than 4,000 Wisconsin residents have signed up.
What is All of Us?
Far too many diseases do not have a proven means of prevention, or effective treatment. We must gain better insights into the biological, environmental, and behavioral influences on these diseases to make a difference for the millions of people who suffer from them. Precision medicine is a revolutionary approach for disease prevention and treatment that considers individual differences in lifestyle, environment, and biology. While some advances in precision medicine have been made, the practice is not currently in use for most diseases.
is a key element of the Precision Medicine Initiative (PMI). Through advances in research, technology, and policies that empower patients, the PMI will enable a new era of medicine in which researchers, health care providers, and patients work together to develop individualized care.
PMI launched in fiscal year 2016 when $130 million was allocated to NIH to build a national, large-scale research participant group, called a cohort, and $70 million was allocated to the National Cancer Institute to lead efforts in cancer genomics as part of PMI for Oncology.
A set of core values is guiding the development and implementation of the All of Us Research Program:
Dr. Dorothy Farrar Edwards